Hydroxymethyl-Glutaryl Coenzyme A Reductase Inhibition Limits Cytomegalovirus Infection in Human Endothelial Cells
- 3 February 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 109 (4) , 532-536
- https://doi.org/10.1161/01.cir.0000109485.79183.81
Abstract
Background— Statins exert anti-inflammatory effects independently of cholesterol-lowering properties. Cytomegalovirus (CMV) infection appears to be implicated in the pathophysiology of atherosclerosis by inducing inflammatory modifications in endothelial cells, especially in immunosuppressed patients. We investigated whether the activity of statins can inhibit replication of CMV in human endothelial cells. Methods and Results— Human umbilical vein endothelial cells (HUVECs) were infected with CMV and coincubated with fluvastatin at 0.1 and 0.2 μmol/L. Fluvastatin inhibited (PP3 pfu/mL, PConclusions— HMG-CoA inhibition by fluvastatin restrains CMV replication in HUVECs by inhibiting viral antigen expression, DNA synthesis, and viral particle production, conceivably by involving a reduction of nuclear factor-κB binding activity.Keywords
This publication has 22 references indexed in Scilit:
- Hydroxymethylglutaryl Coenzyme A Reductase Inhibition Reduces Chlamydia pneumoniae -Induced Cell Interaction and ActivationCirculation, 2003
- Relevance of cytomegalovirus infection and coronary-artery remodeling in the first year after heart transplantation: a prospective three-dimensional intravascular ultrasound studyTransplantation, 2003
- Efficient Lytic Infection of Human Arterial Endothelial Cells by Human Cytomegalovirus StrainsJournal of Virology, 2000
- Atorvastatin reduces NF-κB activation and chemokine expression in vascular smooth muscle cells and mononuclear cellsAtherosclerosis, 1999
- Impact of Prophylactic Immediate Posttransplant Ganciclovir on Development of Transplant AtherosclerosisCirculation, 1999
- Infection in Organ-Transplant RecipientsNew England Journal of Medicine, 1998
- Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B.Journal of Clinical Investigation, 1998
- Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory DiseasesNew England Journal of Medicine, 1997
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Culture of Human Endothelial Cells Derived from Umbilical Veins. IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGIC CRITERIAJournal of Clinical Investigation, 1973